|
Volumn 20, Issue 18, 2002, Pages 3850-3856
|
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOHYDRATE BINDING PROTEIN;
GALECTIN 3;
MONOCLONAL ANTIBODY;
ADULT;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER GRADING;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CARCINOGENESIS;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
FOLLOW UP;
HISTOCHEMISTRY;
HISTOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
KERATINIZATION;
LARYNX CARCINOMA;
MAJOR CLINICAL STUDY;
MULTIVARIATE ANALYSIS;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN ANALYSIS;
PROTEIN EXPRESSION;
RISK ASSESSMENT;
SQUAMOUS CELL CARCINOMA;
TIME;
TREATMENT OUTCOME;
ANTIGENS, DIFFERENTIATION;
CARCINOMA, SQUAMOUS CELL;
CELL DIFFERENTIATION;
DISEASE-FREE SURVIVAL;
DOWN-REGULATION;
GALECTIN 3;
HUMANS;
IMMUNOENZYME TECHNIQUES;
LARYNGEAL NEOPLASMS;
LYMPH NODES;
MIDDLE AGED;
NEOPLASM STAGING;
PROGNOSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0037106507
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2002.01.078 Document Type: Article |
Times cited : (44)
|
References (38)
|